Abstract
Chapter 2 described the economic motivation for health insurance and the financial mechanisms for providing health insurance. This chapter explores the scope of health insurance, and the amount of protection that individuals may seek to obtain for their health capital. The first section of the chapter examines the problem of quantifying and measuring the protection provided by health insurance. Many insurance models assume that the cost of insurance varies with the quantity of protection. The quality and the term of protection are less tangible features that also play a role in determining how much insurance costs and how much protection it provides. The multidimensional nature of health insurance and the trade-offs between the degree of protection and the price of insurance has motivated research investigating the optimal quantity of insurance. While full protection eliminates all exposure to health risks, such insurance may be too costly for individuals or unavailable in the market. Economics focuses on the choice of “optimal” health insurance, and generally finds that partial insurance is optimal for the protection of health capital in the presence of budget constraints. Optimal insurance is therefore the benchmark for determining the suitability of available insurance arrangements as well as the ability of health insurance policy to improve health insurance. The various markets for health insurance often result in individuals obtaining a suboptimal amount of insurance—certain populations are overinsured while others are underinsured or uninsured. This chapter concludes with an exploration of market failures that may explain these suboptimal health insurance arrangements, motivating a deeper investigation of health insurance markets in Sect. 3.2.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
The literature on physician and provider perception of health insurance quality is less developed than the literature on patient and consumer perception and choice of health insurance. Prior studies have found that physicians have a strong opinion that health insurers, among others, “… have a ‘major responsibility’ for reducing healthcare costs …”. The same study, when examining physician’s opinions about third-party payment, found that “Few expressed enthusiasm for ‘eliminating fee-for-service payment models’ (7 %)” (Tilburt et al. 2013). Future research into provider perceptions of health insurance may be a fruitful area for future research.
- 2.
Money itself is not even required in these models. The basic mathematical technique involves what is called a “numeraire” good, or a good whose price and quantity is fixed in order to index the sets of prices and quantities of all other goods (Mas-Colell et al. 1995, p. 325). It is a convenience to consider money to be this good, since it is a unit of exchange with a fixed value, i.e., a dollar has a fixed value of one dollar. In an asset pricing model, it is convenient to think of the numeraire good as a risk-free asset, meaning one with a fixed return (Gollier 2001, p. 332).
- 3.
Governments could also borrow the money, but such borrowing simply passes on the cost to future taxpayers in the form of taxes to repay those bonds.
- 4.
Of course, insurers can ask consumers questions, and then rate the insurance on the basis of individual characteristics (underwriting). There is always a limit to the amount of information a company can obtain from a consumer and use, as well as the possibility that the consumer would misrepresent themselves, i.e., commit fraud. One of the major changes under the ACA is the end of such underwriting in the nongroup market. However, such underwriting has not been a feature of the group or government-provided markets for years (or ever).
- 5.
Note that this assumes that all else is equal between the two claimants, which is clearly not the case. For example, an insurer could use its scale to negotiate a lower price for a given service, thereby paying less when adding together the lower negotiated rate and the cost of adjudicating the claim. That is why the economies of scale and scope are crucial to justifying the use of health insurance on an economic basis.
- 6.
Misrepresenting oneself when the health insurer does ask about health status or other variables is a form of fraud as discussed above concerning underwriting (note iv).
- 7.
It is also important to note that this is not a black and white distinction. “Ex ante moral hazard ” refers to a situation where a person does not undertake preventative behavior in anticipation of being able to address the need for care through insurance in the future (Ehrlich and Becker 1972).
- 8.
There is also a more political question in terms of who derives the most benefit from the current system as it is structured. That question is important because it influences and constrains possible solutions to improve health insurance and health insurance markets. For an in-depth examination, Steven Brill’s “America’s Bitter Pill: Money, Politics, Backroom Deals, and the Fight to Fix Our Broken Healthcare System” serves as an account of how many of these forces shaped the ACA (Brill 2015).
- 9.
Milton Friedman’s “Essays on Positive Economics” providers one extended treatment of positive versus normative economics, with an emphasis on the use of the positive economics method (Friedman 1953).
References
Aizer, A. (2007). Public health insurance, program take-up, and child health. The Review of Economics and Statistics, 89(3), 400–415.
Akerlof, G. A. (1970). The market for “lemons”: Quality uncertainty and the market mechanism. The Quarterly Journal of Economics, 84(3), 488–500.
Armstrong, M., & Chen, Y. (2009). Inattentive consumers and product quality. Journal of the European Economic Association, 7(2–3), 411–422.
Arrow, K. J. (1963). Uncertainty and the welfare economics of medical care. The American Economic Review, 53(5), 941–973.
Baicker, K., Taubman, S. L., Allen, H. L., Bernstein, M., Gruber, J. H., Newhouse, J. P., et al. (2013). The oregon experiment—effects of medicaid on clinical outcomes. New England Journal of Medicine, 368(18), 1713–1722.
Bluhm, W. F. (2007). Individual health insurance. Winsted, CT: ACTEX Publications.
Brill, S. (2015). America’s bitter pill: Money, politics, backroom deals, and the fight to fix our broken healthcare system. New York: Random House.
Centers for Medicare and Medicaid Services. (2015). Closing the coverage Gap—Medicare prescription drugs are becoming more affordable. (No. 11493). Washington, D.C.: Department of Health and Human Services.
Centers for Medicare and Medicaid Services. (2016). Information on essential health benefits (EHB) benchmark plans. Retrieved from https://www.cms.gov/cciio/resources/data-resources/ehb.html
Chernew, M. E., Rosen, A. B., & Fendrick, A. M. (2007). Value-based insurance design. Health Affairs, 26(2), w195–w203.
Chiappori, P., & Salanie, B. (2000). Testing for asymmetric information in insurance markets. The Journal of Political Economy, 108(1), 56.
Cohen, A., & Siegelman, P. (2010). Testing for adverse selection in insurance markets. Journal of Risk and Insurance, 77(1), 39–84.
Craig, P. (1991). Costs and benefits: A review of research on take-up of income-related benefits. Journal of Social Policy, 20(4), 537–565.
Cutler, D. M., & Reber, S. J. (1998). Paying for health insurance: The trade-off between competition and adverse selection. The Quarterly Journal of Economics, 113(2), 433–466.
Cutler, D. M., & Zeckhauser, R. J. (2000). The anatomy of health insurance. In A. J. Culyer & J. P. Newhouse (Eds.), Handbook of health economics (1st ed., pp. 561–643). Amsterdam: Elsevier.
Decker, S. L. (2012). In 2011 nearly one-third of physicians said they would not accept new Medicaid patients, but rising fees may help. Health Affairs, 31(8), 1673–1679.
Ehrlich, I., & Becker, G. S. (1972). Market insurance, self-insurance, and self-protection. Journal of Political Economy, 80(4), 623–648.
Epstein, A. M., Bogen, J., Dreyer, P., & Thorpe, K. E. (1991). Trends in length of stay and rates of readmission in Massachusetts: Implications for monitoring quality of care. Inquiry, 28(1), 19–28.
Frank, R. G., McGuire, T. G., & Newhouse, J. P. (1995). Risk contracts in managed mental health care. Health Affairs, 14(3), 50–64.
Friedman, M. (1953). Essays in positive economics. Chicago: University of Chicago Press.
Gold, M. (1998). Beyond coverage and supply: Measuring access to healthcare in today’s market. Health Services Research, 33(3 Pt 2), 625–684.
Gollier, C. (2001). The economics of risk and time (1st ed.). Cambridge, MA: MIT Press.
Gruber, J. (2008). Covering the uninsured in the United States. Journal of Economic Literature, 46(3), 571–606.
Handel, B. R. (2013). Adverse selection and inertia in health insurance markets: When nudging hurts. The American Economic Review, 103(7), 2643–2682.
Hölmstrom, B. (1979). Moral hazard and observability. Bell Journal of Economics, 10(1), 74–91.
Huang, C., & Litzenberger, R. H. (1988). Foundations for financial economics. Englewood Cliffs, N.J.: Prentice Hall.
Jerant, A., Fiscella, K., & Franks, P. (2012). Health characteristics associated with gaining and losing private and public health insurance. Medical Care, 50(2), 145–151.
Kahneman, D. (2003). Maps of bounded rationality: Psychology for behavioral economics. The American Economic Review, 93(5), 1449–1475.
Kazarosian, M. (1997). Precautionary savings—A panel study. Review of Economics and Statistics, 79(2), 241–247.
Kunreuther, H. C., Pauly, M. V., & McMorrow, S. (2013). Insurance and behavioral economics: Improving decisions in the most misunderstood industry. Cambridge, UK: Cambridge University Press.
Lee, T. M. (2004). An EMTALA primer: The impact of changes in the emergency medicine landscape on EMTALA compliance and enforcement. Annals of Health Law, 13(1), 145–178.
Manning, W. G., Newhouse, J. P., Duan, N., Keeler, E. B., Leibowitz, A., & Marquis, M. S. (1987). Health insurance and the demand for medical care: Evidence from a randomized experiment. The American Economic Review, 77(3), 251–277.
Mas-Colell, A., Whinston, M. D., & Green, J. R. (1995). Microeconomic theory (1st ed.). New York: Oxford University Press.
Mossin, J. (1968). Aspects of rational insurance purchasing. The Journal of Political Economy, 76(4), 553–568.
Munch, P., & Smallwood, D. E. (1980). Solvency regulation in the property-liability insurance industry: Empirical evidence. The Bell Journal of Economics, 11(1), 261–279.
Neumann, P. J. (2004). Using cost-effectiveness analysis to improve health care: Opportunities and barriers. New York: Oxford University Press.
Neuman, P., Cubanski, J., Desmond, K. A., & Rice, T. H. (2007). How much ‘skin in the game’ do medicare beneficiaries have? The increasing financial burden of health care spending, 1997–2003. Health Affairs, 26(6), 1692–1701.
Newhouse, J. P., & Byrne, D. J. (1988). Did medicare’s prospective payment system cause length of stay to fall?. Journal of Health Economics, 7(4), 413–416.
Organization for Economic Cooperation and Development (OECD). (2013). Health at a glance 2013: OECD indicators. Paris: OECD.
Osborne, M. J., & Rubinstein, A. (1994). A course in game theory. Cambridge, MA: MIT Press.
Patient Protection and Affordable Care Act, 42 U.S.C. § 18001 (2010).
Pauly, M. V. (1968). The economics of moral hazard: Comment. The American Economic Review, 58(3), 531–537.
Pauly, M. V. (2000). Optimal health insurance. The Geneva Papers on Risk and Insurance. Issues and Practice, 25(1), 116–127.
Pauly, M. V., & Lieberthal, R. D. (2008). How risky is individual health insurance?. Health Affairs, 27(3), w242–w249.
Pauly, M. V., & Satterthwaite, M. A. (1981). The pricing of primary care physicians services: A test of the role of consumer information. The Bell Journal of Economics, 12(2), 488–506.
Phelps, C. E. (2003). Health economics (3rd ed.). Boston: Addison-Wesley.
Pratt, J. W. (1964). Risk aversion in the small and in the large. Econometrica, 32(1/2), 122–136.
Reid, R. O., Deb, P., Howell, B. L., & Shrank, W. H. (2013). Association between Medicare Advantage plan star ratings and enrollment. Journal of the American Medical Association, 309(3), 267–274.
Richter, A., Schiller, J., & Schlesinger, H. (2014). Behavioral insurance: Theory and experiments. Journal of Risk and Uncertainty, 48(2), 85–96.
Rothschild, M., & Stiglitz, J. (1976). Equilibrium in competitive insurance markets: An essay on the economics of imperfect information. The Quarterly Journal of Economics, 90(4), 629–649.
Schlesinger, H. (1981). The optimal level of deductibility in insurance contracts. Journal of Risk and Insurance, 48(3), 465–481.
Silverman, E., & Skinner, J. (2004). Medicare upcoding and hospital ownership. Journal of Health Economics, 23(2), 369–389.
Sommers, B. D., Baicker, K., & Epstein, A. M. (2012). Mortality and access to care among adults after state medicaid expansions. New England Journal of Medicine, 367(11), 1025–1034.
Sommers, B. D., Long, S. K., & Baicker, K. (2014). Changes in mortality after Massachusetts health care reform: A quasi-experimental study. Annals of Internal Medicine, 160(9), 585–593.
Tabák, A. G., Jokela, M., Akbaraly, T. N., Brunner, E. J., Kivimäki, M., & Witte, D. R. (2009). Trajectories of glycemia, insulin sensitivity and insulin secretion preceding the diagnosis of type 2 diabetes: The Whitehall II study. The Lancet, 373(9682), 2215–2221.
Thompson, J. W., Bost, J., Faruque, A., Ingalls, C. E., & Sennett, C. (1998). The NCQA’s quality compass: Evaluating managed care in the united states. Health Affairs, 17(1), 152.
Tilburt, J. C., Wynia, M. K., Sheeler, R. D., Thorsteinsdottir, B., James, K. M., Egginton, J. S., et al. (2013). Views of US physicians about controlling health care costs. Journal of the American Medical Association, 310(4), 380–389.
Varian, H. R. (1992). Microeconomic analysis (3rd ed.). New York: W.W. Norton and Company.
Winter, R. A. (2000). Optimal insurance under moral hazard. In G. Dionne (Ed.), Handbook of insurance (pp. 155–183). Dordrecht, Netherlands: Springer.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lieberthal, R.D. (2016). The Scope of Health Insurance. In: What Is Health Insurance (Good) For?. Springer, Cham. https://doi.org/10.1007/978-3-319-43796-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-43796-5_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43795-8
Online ISBN: 978-3-319-43796-5
eBook Packages: Economics and FinanceEconomics and Finance (R0)